?
Mccourt Marion
EVP Commercial
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK
1663758
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
12,931
Price per Share :
$703.43
Equivalence :
$9,096,053.33
Transaction History
-
S12,931 Shares After TransactionValue : $11,500,960.71Sold $222,352.50Transaction Date : 05/01/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.
-
M14,068 Shares After TransactionValue : $5,239,767.28$423,487.02Transaction Date : 08/01/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024.
-
S12,931 Shares After TransactionValue : $13,717,980.66Sold $1,206,197.82Transaction Date : 08/01/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024.
-
A15,263 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/06/24
-
Footnotes
-
-
Footnotes:#1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
-
F14,989 Shares After TransactionValue : $11,796,343.00$215,638.00Transaction Date : 12/09/24
-
Footnotes
-
-
Footnotes:#1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.